Peter Johnson to Drug Administration Schedule
This is a "connection" page, showing publications Peter Johnson has written about Drug Administration Schedule.
Connection Strength
0.696
-
Intramuscular Lorazepam for Status Epilepticus in Children With Complex Medical and Physical Disabilities. Ann Pharmacother. 2017 Aug; 51(8):656-662.
Score: 0.138
-
Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion. J Opioid Manag. 2015 Jul-Aug; 11(4):295-303.
Score: 0.122
-
External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother. 2014 Feb; 48(2):187-95.
Score: 0.109
-
A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Res Social Adm Pharm. 2012 Sep-Oct; 8(5):455-63.
Score: 0.096
-
Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8.
Score: 0.094
-
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. A A Case Rep. 2017 May 01; 8(9):242-245.
Score: 0.035
-
"Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. Am J Health Syst Pharm. 2014 Dec 15; 71(24):2108-9.
Score: 0.029
-
Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother. 2013 Sep; 47(9):1130-5.
Score: 0.027
-
Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012 Sep 01; 69(17):1458, 1460-1.
Score: 0.025
-
Increased enoxaparin dosing is required for obese children. Pediatrics. 2011 Mar; 127(3):e787-90.
Score: 0.022